US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Agile Therapeutics Inc (AGRX)
Agile Therapeutics Inc (AGRX) ニュース

AGRX

Agile Therapeutics (AGRX)

Agile Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AGRX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/28	21 : 05	GlobeNewswire Inc.	Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:AGRX	Agile Therapeutics Inc
2024/03/26	05 : 30	GlobeNewswire Inc.	Agile Therapeutics Announces Delisting from Nasdaq	NASDAQ:AGRX	Agile Therapeutics Inc
2024/03/21	19 : 35	GlobeNewswire Inc.	Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024	NASDAQ:AGRX	Agile Therapeutics Inc
2024/03/20	21 : 15	GlobeNewswire Inc.	Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024	NASDAQ:AGRX	Agile Therapeutics Inc
2024/03/13	20 : 31	GlobeNewswire Inc.	Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution	NASDAQ:AGRX	Agile Therapeutics Inc
2024/02/24	06 : 57	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:AGRX	Agile Therapeutics Inc
2024/02/24	06 : 55	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:AGRX	Agile Therapeutics Inc
2024/02/22	23 : 01	GlobeNewswire Inc.	Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds	NASDAQ:AGRX	Agile Therapeutics Inc
2024/02/16	06 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGRX	Agile Therapeutics Inc
2024/02/16	06 : 30	GlobeNewswire Inc.	Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update	NASDAQ:AGRX	Agile Therapeutics Inc
2024/02/14	10 : 02	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AGRX	Agile Therapeutics Inc
2024/02/08	06 : 51	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:AGRX	Agile Therapeutics Inc
2024/02/07	00 : 14	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AGRX	Agile Therapeutics Inc
2024/02/05	23 : 21	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:AGRX	Agile Therapeutics Inc
2024/02/03	06 : 27	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:AGRX	Agile Therapeutics Inc
2024/01/23	23 : 29	GlobeNewswire Inc.	The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost	NASDAQ:AGRX	Agile Therapeutics Inc
2023/12/20	22 : 00	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:AGRX	Agile Therapeutics Inc
2023/12/12	22 : 01	GlobeNewswire Inc.	Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirement	NASDAQ:AGRX	Agile Therapeutics Inc
2023/12/12	07 : 30	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:AGRX	Agile Therapeutics Inc
2023/12/06	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGRX	Agile Therapeutics Inc
2023/12/04	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGRX	Agile Therapeutics Inc
2023/11/10	06 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AGRX	Agile Therapeutics Inc
2023/11/09	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGRX	Agile Therapeutics Inc
2023/11/09	22 : 05	GlobeNewswire Inc.	Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:AGRX	Agile Therapeutics Inc
2023/10/26	21 : 05	GlobeNewswire Inc.	Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023	NASDAQ:AGRX	Agile Therapeutics Inc
2023/10/05	05 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGRX	Agile Therapeutics Inc
2023/10/05	05 : 30	GlobeNewswire Inc.	Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:AGRX	Agile Therapeutics Inc
2023/10/03	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGRX	Agile Therapeutics Inc
2023/09/29	05 : 50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGRX	Agile Therapeutics Inc
2023/09/05	21 : 05	GlobeNewswire Inc.	Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:AGRX	Agile Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:AGRX

1 2 3 4 5 6 7 8 9 10 次へ >>

BNP Paribas (QX)

Energy Select Sector SPDR

US Dollar vs Sterling

Invesco QQQ Trust Series 1

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約